Listed

Immuneering Corp

IMRXNasdaqCIK 1790340HealthcareFiscal year ends Dec 31

Reports and events: 79 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Immuneering Corp, Reports and events
FiledFormWhat it isAccession number
2023-06-1416:08 ET8-K5.02 Departure or appointment of officers or directors0001790340-23-000025
2023-05-0416:04 ET10-QQuarterly reportPeriod 2023-03-310001790340-23-000023
2023-05-0416:03 ET8-K9.01 Financial statements and exhibits0001790340-23-000022
2023-05-0107:28 ETDEF 14AProxy statementPeriod 2023-05-010001790340-23-000011
2023-04-1916:07 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-23-047191
2023-04-1809:04 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-23-046455
2023-03-0616:06 ET10-KAnnual reportPeriod 2022-12-310001558370-23-002905
2023-03-0616:05 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-23-002901
2022-11-1009:05 ET10-QQuarterly reportPeriod 2022-09-300001558370-22-017304
2022-11-1009:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-22-017302
2022-09-1916:30 ET8-K/A5.02 Departure or appointment of officers or directors0001104659-22-101186
2022-08-1016:09 ET10-QQuarterly reportPeriod 2022-06-300001558370-22-013063
2022-08-1016:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-22-013057
2022-07-2507:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-22-082207
2022-06-2416:06 ET8-K5.07 Shareholder vote results0001104659-22-074300
2022-05-1006:36 ET10-QQuarterly reportPeriod 2022-03-310001558370-22-007953
2022-05-1006:32 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-22-007951
2022-05-0207:01 ETDEF 14AProxy statementPeriod 2022-06-210001104659-22-054083
2022-03-1006:38 ET10-KAnnual reportPeriod 2021-12-310001558370-22-003208
2022-03-1006:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-22-003205
2022-01-1806:56 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-22-004651
2021-12-2206:04 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-152368
2021-11-0906:36 ET10-QQuarterly reportPeriod 2021-09-300001558370-21-015147
2021-11-0906:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-21-015144
2021-09-0906:41 ET10-QQuarterly reportPeriod 2021-06-300001558370-21-012336
2021-09-0906:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-21-012334
2021-07-2807:40 ETS-1/ARegistration statement, amended0001104659-21-096615
2021-07-2606:03 ETS-1/ARegistration statement, amended0001104659-21-095557
2021-07-0916:02 ETS-1Registration statement0001104659-21-090635

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 03:06 ET. Listed shows no prices and gives no investment advice.